Cargando…
Involved site radiation therapy in stage I-III nasopharyngeal carcinoma with limited lymph node burden (ISRT-NPC) or elective region irradiation: a study protocol for a multicenter non-inferiority randomized controlled phase III clinical trial
BACKGROUND: Current radiotherapy guidelines and consensus statements uniformly recommend elective region irradiation (ERI) as the standard strategy for nasopharyngeal carcinoma (NPC). However, given the scarcity of skip-metastasis, the improved assessment accuracy of nodal involvement, and the strik...
Autores principales: | Liu, Yang, Han, Yaqian, Liu, Feng, Hu, Desheng, Chen, Zhijian, Wang, Peiguo, Li, Jingao, Qin, Jiyong, Jin, Feng, Li, Yexiong, Wang, Jingbo, Yi, Junlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401746/ https://www.ncbi.nlm.nih.gov/pubmed/37537541 http://dx.doi.org/10.1186/s12885-023-11212-7 |
Ejemplares similares
-
P025: RADAR: An international phase III, PET response-adapted, randomised trial in progress, comparing ABVD±ISRT with brentuximab vedotin+AVD±ISRT in patients with previously untreated limited-stage classical Hodgkin lymphoma
por: Radford, John, et al.
Publicado: (2022) -
Immune surveillance of nasopharyngeal carcinoma (NpC)
por: Oluwadara, Oluwadayo, et al.
Publicado: (2011) -
Plasma levels of soluble programmed death ligand 1 (sPD-L1) in WHO II/III nasopharyngeal carcinoma (NPC): A preliminary study
por: Yang, Jia, et al.
Publicado: (2019) -
Primary Treatment Results of Nasopharyngeal Carcinoma (NPC) in Yogyakarta, Indonesia
por: Wildeman, Maarten A., et al.
Publicado: (2013) -
A Rare Presentation of Primary Nasopharyngeal Carcinoma (NPC) in Mediastinum
por: Fathi, Afshin, et al.
Publicado: (2016)